Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05180448 · ClinicalTrials.gov registry record · NA
Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 322
- Enrollment target
NCT05180448: Completed NA study, sponsored by Drexel University.
NCT05180448 is a NA study that has completed, run by Drexel University. The registered enrollment target is 322 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05180448, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 322 participants
- Enrollment target
Study Summary
Adults attempting weight loss through lifestyle modification (LM) typically find maintenance of behavior change difficult. Outcomes might be improved if participants are provided with sustained sources of accountability and support and ongoing opportunities to reflect with others on goal progress. This study proposes that sharing digital data with other parties has the potential to improve long-term weight loss. The proposed study will enroll adults ("index participants") (N = 320) with overweight/obesity in a 24-month LM program and instruct them to use digital tools for self-monitoring of weight, physical activity, and eating on a daily basis.
Primary Outcome
Weight will be measured using a wireless scale. In order to maximize accuracy, we will (1) provide instructions (e.g., place scale on flat, hard surface; weigh upon waking, without clothes, after using the bathroom), (2) require participants to confirm that they are following instructions at each assessment point, (3) remove errant weights (e.g., \>1 kg change in 1 day).
Interventions
- BEHAVIORAL Coach Share On
- BEHAVIORAL Group Share On
- BEHAVIORAL Friend/Family Share On
- BEHAVIORAL Coach Share Off
- BEHAVIORAL Group Share Off
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 322 participants |
| Start Date | 2022-01-03 |
| Est. Completion | 2025-07-30 |
| Phase | NA |
What the finished NCT05180448 record still lists
NCT05180448 is an interventional study that assigns participants to a tested intervention. The registered 322 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 5 interventions - of which Coach Share On is the first listed.
NCT05180448 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05180448 about?
NCT05180448 is a clinical study titled "Sharing Digital Self-Monitoring Data With Others to Enhance Long-Term Weight Loss". Adults attempting weight loss through lifestyle modification (LM) typically find maintenance of behavior change difficult. Outcomes might be improved if participants are provided with sustained sources of accountability and support and ongoing opportunities to reflect with others on goal progress. T...
What is the current status of trial NCT05180448?
This trial is currently completed. It is a NA study. The enrollment target is 322 participants. The study started on 2022-01-03. Estimated completion is 2025-07-30.
What interventions are being tested in trial NCT05180448?
The interventions under investigation include: Coach Share On (BEHAVIORAL), Group Share On (BEHAVIORAL), Friend/Family Share On (BEHAVIORAL), Coach Share Off (BEHAVIORAL), Group Share Off (BEHAVIORAL).
Who is sponsoring clinical trial NCT05180448?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05180448's enrollment target sits among peer trials
322 315th of 2000 higher than 1,686 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04090359 · 322 participants · Phase 4
Dual Mobility Acetabular Cups in Revision TJA
- NCT04924075 · 322 participants · Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- NCT03715933 · 321 participants · Phase 1
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- NCT05922878 · 321 participants · Phase 2
Study of ALTO-300 in MDD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI